focus -WSS

focus

author：leisure time 2025-08-12 06:42:14 - browse：5195

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： A Theranos scientist

WSS

Why you get paid to donate plasma but not blood

Vertex non

Zyn nicotine pouches become unlikely player in latest culture war

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

hotspot

focus

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

A look at other Americans who have crossed into North Korea over the years

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medicare drug price negotiation legal challenge met with skepticism

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Twill hunts for pharma partner to market its depression app

Continuity nursing helped my family in our darkest PICU moments

Merck, Johnson & Johnson CEOs will testify on high drug prices

Hepatitis C has a cure — but many Americans still lack access to it

Biogen walks away from Aduhelm, years after polarizing approval

leisure time

FTC sues over Novant Health acquisition of two N.C. hospitals

US soldier in North Korean custody after crossing DMZ line

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Syphilis numbers in the United States reach record heights

FDA seeking to stop procedures at two unregulated stem cell clinics

focus

Wikipedia

focus

explore